Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
09/2004
09/22/2004CN1531525A Organic compounds
09/22/2004CN1531425A Urea derivatives as integrin alpha 4 antagonists
09/22/2004CN1167673C Fluorovinyloxyacetamides, process for preparing the same and herbicidal composition comprising the same
09/21/2004US6794521 Catalyzing the nitrating reaction with thiophene and nitric acid in the presence of a solid acid catalyst montmorillonite clay
09/21/2004US6794400 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
09/21/2004US6794392 Cell differentiation inducer
09/16/2004WO2004078747A1 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
09/16/2004WO2004058149A3 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles
09/16/2004WO2004050653A3 Oxime ester photoinitiators with heteroaromatic groups
09/16/2004WO2004026264A3 Novel aromatic compounds possessing antifungal or antibacterial activity
09/16/2004WO2003096989A3 Anti tubercular drug: compositions and methods
09/16/2004WO2003028729A3 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
09/16/2004US20040181075 Process of making chalcone derivatives
09/16/2004US20040181067 Tri(cyclo) substituted amide compounds
09/16/2004US20040181058 intermediates for preparing active compounds in medicaments selected from the group consisting of serotonin or noradrenaline uptake inhibitors
09/16/2004US20040180964 anti-obestic activity; Neuropeptide Y antagonist
09/16/2004US20040180948 2-Amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors
09/16/2004US20040180947 Sulfonamide compounds and pharmaceutical use thereof
09/16/2004US20040180932 Benzothiophenes, formulations containing same, and methods
09/16/2004US20040180892 control of cardiovascular homeostasis is achieved through a combination of both direct neuronal control and systemic neurohormonal activation
09/16/2004US20040180883 Central nervous system disorders; such as 7-{2-[4-(6-Fluorobenzothiophen-3-yl)-2-methylpiperazin-1-yl]ethyl}-4,5-dihydro-7H-thieno[2,3-c]pyran-2-carboxamide
09/16/2004US20040180877 Nicotinic acetylcholine receptor cholinergic ligands, monoamine receptor and transporter modulators; such as 1-(2-Benzo[b]thiophenyl-1,1-dioxide)-imidazolidine
09/16/2004US20040180871 Anti-inflammatory compositions and methods
09/16/2004US20040180829 Compounds and methods for regulating bacterial growth and pathogenesis
09/15/2004EP1456737A2 System and method for displaying editorial content through television navigation controls and electronic program guides
09/15/2004EP1456196A1 Benzothiophenes as adenosine receptor modulators
09/15/2004EP1455777A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
09/15/2004EP1254135B1 Aminoheterocyclylamides as pesticides and antiparasitic agents
09/15/2004EP0986384A4 Inhibitors of protein isoprenyl transferases
09/15/2004CN1529695A Anthranilic acid amides with heteroarylsulfonyl side chain, method for production thereof, use thereof as medicament or diagnostic agent and phamaceutical preparations containing same
09/15/2004CN1529692A N-arylphenylacetamide derivatives and medicinal compositions containing same
09/15/2004CN1528760A Monomer containing bisbenzothiophene dioxide group and preparing method thereof
09/15/2004CN1166659C Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites
09/15/2004CN1166614C Indandione compounds and its preparing process and application
09/14/2004US6790997 Oxidation of alcohols in the presence of osmium compounds as catalysts in water or a solvent mixture
09/14/2004US6790973 Reduction of ketone to alcohol using complex catalyst
09/14/2004US6790866 Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient
09/14/2004US6790834 Cytostatic agents
09/14/2004CA2280708C Cetp activity inhibitors
09/14/2004CA2264549C Spirocyclic dopamine receptor subtype ligands
09/14/2004CA2103110C Insecticidal n'-substituted-n,n'-diacylhydrazines
09/10/2004WO2004076475A1 A method of generating metal chelating affinity ligands
09/10/2004WO2004076434A1 Dipeptidyl peptidase inhibitors
09/10/2004WO2004076433A1 Dipeptidyl peptidase inhibitors
09/10/2004WO2004056755A3 Compounds for the inhibition of non-proteolytic enzymes
09/10/2004WO2004056727A8 Process of making chalcone derivatives
09/10/2004WO2004053087A3 Nf-κb inhibitors
09/10/2004WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators
09/10/2004WO2004041211A3 INHIBITORS OF β-SECRETASE, AND THEIR USE FOR THE PREVENTION OR TREATMENT OF ALZHEIMER’S DISEASE OR MILD COGNITIVE IMPAIRMENT
09/10/2004WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives
09/10/2004CA2517231A1 A method of generating metal chelating affinity ligands
09/09/2004US20040176595 Glucocorticoid receptor modulators
09/09/2004US20040176560 One arylene group suitable for semiconductors or charge transfer agents for optical, electrooptical or electronic device including transistors, electroluminescent and detector devices
09/09/2004US20040176471 Novel chalcone derivatives and pharmaceutical compositions comprising the same
09/09/2004US20040176462 NPY Y5 antagonist
09/09/2004US20040176461 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents;
09/09/2004US20040176458 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
09/09/2004US20040176445 Propionic acid derivatives
09/09/2004US20040176435 example compound: (3S)-3-(1-Benzothien-7-yloxy)-N-methyl-3-phenyl-1-propanamine oxalate; depression, OCD, anxiety, memory loss, urinary incontinence, conduct disorders, ADHD, obesity, alcoholism, smoking cessation and pain
09/09/2004US20040175747 2-(Mercaptoalkylenecarbonyl)-thiophene derivative capable of forming a self-assembled monolayer having a uniform thickness
09/09/2004DE10306502A1 Substituierte 3-(Benzoylureido)-thiophenderivate, Verfahren zu deren Herstellung und deren Verwendung Substituted 3- (Benzoylureido) -thiophenderivate, processes for their preparation and their use
09/08/2004EP1454906A1 Conductive compound, electrode and sensor containing the same, and target molecule detection method using the sensor
09/08/2004EP1453794A1 Novel amidine derivatives and the use of the same in pharmaceuticals
09/08/2004EP1453792A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
09/08/2004EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/08/2004EP1453514A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
09/08/2004EP1453501A1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
09/08/2004EP0944581A4 Process of preparing substituted acrylamides
09/08/2004CN1527820A 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders
09/08/2004CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications
09/08/2004CN1165522C Bradykinin receptor antagonists
09/07/2004US6787621 Using diarylethene monomers for making photochromic polymerizable thin film
09/07/2004US6787536 Hydroxamic acid derivatives
09/07/2004CA2105709C Substituted cyclohexane derivatives, processes for their preparation and the use of the compounds for treating diseases
09/02/2004WO2004074271A1 Nitrate esters of phenylaminothiophenacetic acid derivatives
09/02/2004WO2004074242A2 Halogenated oxime derivatives and the use thereof as latent acids
09/02/2004WO2004073709A1 Antimicrobial agents
09/02/2004WO2004073634A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
09/02/2004WO2004073606A2 Sulfonamide derivatives as ppar modulators
09/02/2004WO2004041256A3 Safe chemical uncouplers for the treatment of obesity
09/02/2004WO2003049698A8 Substituted hydrazones as inhibitors of cyclooxygenase-2
09/02/2004US20040171882 Reacting nopinone with a modified ester; converting to oxime; reducing with aluminum hydride
09/02/2004US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/02/2004US20040171833 Ligands for metals and improved metal-catalyzed processes based thereon
09/02/2004US20040171670 Neurological diseases and disorders; such as 3-fluoro-10,11-dihydro-5-(2-aminoethyl)-5H-dibenzo[a,d]cycloheptene
09/02/2004US20040171641 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)
09/02/2004US20040171612 Novel compounds with analgesic effect
09/02/2004US20040171543 Matrix metalloproteinase inhibitors and methods for identification of lead compounds
09/02/2004US20040171491 Substituted benzoylcyclohexenones and their use as herbicidal agents
09/02/2004US20040171001 Comprises cationic, water-soluble polythiophene derivatives, which can readily transduce oligonucleotide hybridization into a clearly interpretable optical (colorimetric, fluorescent or luminescent) or electrical signal
09/02/2004US20040170863 Organic electroluminescent devices using double-spiro organic compounds
09/02/2004US20040169463 Aryl-aryl dendrimers
09/02/2004US20040168983 Method of generating metal chelating affinity ligands
09/02/2004CA2767153A1 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
09/02/2004CA2515971A1 Nitrate esters of phenylaminothiophenacetic acid derivatives
09/02/2004CA2512883A1 Sulfonamide derivatives as ppar modulators
09/02/2004CA2511979A1 Halogenated oxime derivatives and the use thereof as latent acids
09/01/2004EP1452522A2 Novel compounds and compositions as protease inhibitors
09/01/2004EP1451195A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
09/01/2004EP1451171A1 Method for preparing chiral amines